Confido Health
Seed Round in 2024
Confido Health provides AI-driven solutions that automate healthcare operations, including appointment management and patient follow-ups, by integrating with existing clinical systems to reduce administrative burdens. Its platform uses artificial intelligence to streamline routine tasks and improve communication among staff, patients, and other stakeholders, enabling clinics and surgery centers to operate more efficiently and focus on patient care. The company aims to enhance care quality by cutting unnecessary administrative time and optimizing workflows across care teams.
AvoMD is a no-code software platform that converts clinical content into 'virtual clinical consults', providing instant expert guidance at the bedside. It improves healthcare outcomes while saving clinicians approximately half of their time spent on accessing and using information.
Gradient Health
Seed Round in 2023
Gradient Health is a developer of an open research platform that specializes in AI-based medical imaging diagnostics and infrastructure. The company provides a comprehensive platform that includes access to a full clinical sandbox, open-source tools, and documentation, all designed to facilitate the translation of research into a secure and interoperable clinical environment. By offering these resources, Gradient Health aims to support developers in advancing medical imaging technologies and improving diagnostic processes using artificial intelligence.
Eddii is a company that develops a health tracking application aimed at individuals living with diabetes. The app features a virtual character designed to engage users through gamification and interactive conversations, encouraging them to record their wellness data daily and adhere to healthy routines. Eddii provides helpful tips via weekly reports and rewards users for maintaining healthy practices and performance within the app.
Epitel is a digital health company developing a wearable, wireless EEG monitoring platform that enables accessible, reliable seizure detection. The system combines a cloud-based wearable sensor network with artificial intelligence to identify electrographic seizures, providing brain health insights for physicians, caregivers, and patients with neurological disorders to improve quality of life and care.
Options MD
Pre Seed Round in 2021
Options MD is a telemedicine platform that employs AI-driven algorithms to match individuals with severe or treatment-resistant mental illnesses to personalized care options. It then connects these patients with in-house psychiatric experts for appropriate medical assistance.
Options MD
Pre Seed Round in 2021
Options MD is a telemedicine platform that employs AI-driven algorithms to match individuals with severe or treatment-resistant mental illnesses to personalized care options. It then connects these patients with in-house psychiatric experts for appropriate medical assistance.
Inherent Biosciences
Seed Round in 2021
Inherent Biosciences is a molecular diagnostics company focused on transforming the traditional trial and error approach in medicine. The company leverages its innovative epigenetic medicine platform to address various health challenges by identifying gene dysregulation and its associated pathways. By translating biological insights into actionable information, Inherent Biosciences aims to enhance treatment strategies for conditions such as pain, infertility, embryo quality, autism, rheumatoid arthritis, psoriatic arthritis, fetal heart disease, and COVID-19. This approach not only guides healthcare professionals in managing complex diseases but also seeks to provide personalized insights that empower patients in their health journeys.